Michigan Medicine and MedImmune, the global biologics research and development arm of AstraZeneca (NYSE: AZN), have entered into a three-year research alliance to identify potential new therapies for the prevention and treatment of diabetes, obesity and related metabolic disorders.
People with diabetes who rely on insulin have seen the cost of that drug triple in just a decade -- even as doctors have prescribed higher doses to drive down their blood sugar levels. Meanwhile, the cost of other diabetes drugs has stayed about the same or even gone down.
It started out as a treatment for arthritis. But steered by science, it could become a first new approach in two decades for treating the damage that diabetes inflicts on the kidneys of millions of people.
Day in and day out, for years on end, millions of people with diabetes prick their fingers to test their blood sugar level. And many may wonder if all the careful eating, exercise and medication it takes to keep those levels under control is really worth it. A major new study should encourage them to keep going for the long haul.
Screening to identify Type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research that combined large scale clinical observations and innovative computer modelling.
How can we keep more people from joining the ranks of the 29 million Americans already diagnosed with diabetes? What if we could tell with precision who has the highest risk of developing the disease, and figure out which preventive steps are most likely to help each of them individually? Researchers have just released a “precision medicine” approach to diabetes prevention that could do just that – using existing information, and without needing new genetic tests.
Research program will investigate an exciting new hypothesis about lost beta cell function in type 1 diabetes that may change our basic understanding of the disease and lead to novel prevention and restoration therapies.
Anyone who has seen a young relative cope with a new diagnosis of type 1 diabetes – or an adult relative handle the daily demands of the lifelong illness – knows what a toll it can take. Now, it’s even easier than ever for relatives of type 1 diabetes patients to help U-M researchers in the search for ways to prevent or delay the disease.
Researchers at the University of Michigan Kellogg Eye Center have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy. The finding is significant because it could lead to a novel therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects the retina.
The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2012-13 Best Children's Hospitals rankings.
On March 8, the University of Michigan Health System will host a World Kidney Day event that includes free kidney, blood pressure and depression screenings, plus prize raffles and information about kidney transplantation.
Experts at the University of Michigan Comprehensive Diabetes Center are available to discuss the impact of diet on diabetes following the announcement this week that Southern chef Paula Deen has type 2 diabetes.
Want to know how well UMHS does at providing high-quality care and protecting patients' safety while they receive care? Check out the newly updated data on a website that provides these data, patient ratings of UMHS care, and much more, to the public.